These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20477714)

  • 1. Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.
    Ciborowski P
    Biomark Med; 2009 Dec; 3(6):771-85. PubMed ID: 20477714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Pannexin-1 Channels in HIV and NeuroHIV Pathogenesis.
    Hernandez CA; Eliseo E
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.
    Tavazzi E; Morrison D; Sullivan P; Morgello S; Fischer T
    Curr HIV Res; 2014; 12(2):97-110. PubMed ID: 24862332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
    J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
    Kaul M
    Curr Opin Neurol; 2009 Jun; 22(3):315-20. PubMed ID: 19300249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-associated neurocognitive disorder.
    Smail RC; Brew BJ
    Handb Clin Neurol; 2018; 152():75-97. PubMed ID: 29604986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic biomarkers for HAND.
    McLaurin KA; Booze RM; Mactutus CF
    J Neurovirol; 2019 Oct; 25(5):686-701. PubMed ID: 30607890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation.
    Roberts TK; Eugenin EA; Morgello S; Clements JE; Zink MC; Berman JW
    Am J Pathol; 2010 Oct; 177(4):1848-60. PubMed ID: 20724601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of HIV Infection in Neurologic Injury.
    Scutari R; Alteri C; Perno CF; Svicher V; Aquaro S
    Brain Sci; 2017 Apr; 7(4):. PubMed ID: 28383502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated neurocognitive disorder.
    Clifford DB; Ances BM
    Lancet Infect Dis; 2013 Nov; 13(11):976-86. PubMed ID: 24156898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
    Duran-Castells C; Llano A; Kawana-Tachikawa A; Prats A; Martinez-Zalacain I; Kobayashi-Ishihara M; Oriol-Tordera B; Peña R; Gálvez C; Silva-Arrieta S; Clotet B; Riveira-Muñoz E; Ballana E; Prado JG; Martinez-Picado J; Sanchez J; Mothe B; Hartigan-O'Connor D; Wyss-Coray T; Meyerhans A; Gisslén M; Price RW; Soriano-Mas C; Muñoz-Moreno JA; Brander C; Ruiz-Riol M
    J Virol; 2023 Feb; 97(2):e0165522. PubMed ID: 36719240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.
    Fields JA; Spencer B; Swinton M; Qvale EM; Marquine MJ; Alexeeva A; Gough S; Soontornniyomkij B; Valera E; Masliah E; Achim CL; Desplats P
    J Neurochem; 2018 Dec; 147(6):784-802. PubMed ID: 30152135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment.
    Scanlan A; Zhang Z; Koneru R; Reece M; Gavegnano C; Anderson AM; Tyor W
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.
    Vreeman RC; Scanlon ML; McHenry MS; Nyandiko WM
    J Int AIDS Soc; 2015; 18(Suppl 6):20258. PubMed ID: 26639114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on HIV dementia and HIV-associated neurocognitive disorders.
    Brew BJ; Chan P
    Curr Neurol Neurosci Rep; 2014 Aug; 14(8):468. PubMed ID: 24938216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive Impairment and Associated Genetic Aspects in HIV Infection.
    Gomez D; Power C; Fujiwara E
    Curr Top Behav Neurosci; 2021; 50():41-76. PubMed ID: 30523615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.